Personal information

Verified email domains

Activities

Employment (1)

University of Washington: WA, WA, US

2020-10-05 to 2022-05-16 | Research Scientist (Biochemistry-Institute for Protein Design)
Employment
Source: Self-asserted source
Max Johnson

Education and qualifications (2)

Stanford University School of Medicine: Stanford, CA, US

2022-08 to present | MD Candidate (Medicine)
Education
Source: Self-asserted source
Max Johnson

University of Wisconsin–Oshkosh: Oshkosh, Wisconsin, US

2016-09 to 2020-05 | BS in Chemistry (Chemistry)
Education
Source: Self-asserted source
Max Johnson

Works (13)

Computationally designed mRNA-launched protein nanoparticle vaccines

2024-07-23 | Preprint
Contributors: Grace G Hendricks; Lilit Grigoryan; Mary Jane Navarro; Nicholas J. Catanzaro; Miranda L. Hubbard; John M. Powers; Melissa Mattocks; Catherine Treichel; Alexandra C. Walls; Jimin Lee et al.
Source: Self-asserted source
Max Johnson

Career Trajectory After General Surgery Residency

Annals of Surgery
2024-04-23 | Journal article
Part of ISSN: 0003-4932
Contributors: Allen Green; Elijah R. Sommer; Max R. Johnson; Hector Gonzalez; Twan Sia; David A. Spain; Jeff Choi
Source: Self-asserted source
Max Johnson
grade
Preferred source (of 2)‎

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.

Nature communications
2023-09-13 | Journal article
Part of ISSN: 2041-1723
Contributors: Anindya Roy; Lei Shi; Ashley Chang; Xianchi Dong; Andres Fernandez; John C Kraft; Jing Li; Viet Q Le; Rebecca Viazzo Winegar; Gerald Maxwell Cherf et al.
Source: check_circle
Stanford University

De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8.

bioRxiv : the preprint server for biology
2023-06-12 | Journal article
Contributors: Anindya Roy; Lei Shi; Ashley Chang; Xianchi Dong; Andres Fernandez; John C Kraft; Jing Li; Viet Q Le; Rebecca Viazzo Winegar; Gerald Maxwell Cherf et al.
Source: check_circle
Stanford University

Computational design of constitutively active cGAS

Nature Structural & Molecular Biology
2023-01 | Journal article
Part of ISSN: 1545-9993
Part of ISSN: 1545-9985
Contributors: Quinton M. Dowling; Hannah E. Volkman; Elizabeth E. Gray; Sergey Ovchinnikov; Stephanie Cambier; Asim Bera; banumathi Sankaran; Max R. Johnson; Matthew Bick; Alex Kang et al.
Source: Self-asserted source
Max Johnson

Antigen- and scaffold-specific antibody responses to protein nanoparticle immunogens

Cell Reports Medicine
2022-10 | Journal article
Part of ISSN: 2666-3791
Contributors: John Kraft; Minh N. Pham; Laila Shehata; Mitch Brinkkemper; Seyhan Boyoglu-Barnum; Kaitlin R. Sprouse; Alexandra C. Walls; Suna Cheng; Mike Murphy; Deleah Pettie et al.
Source: Self-asserted source
Max Johnson

Vaccination with a structure-based stabilized version of malarial antigen Pfs48/45 elicits ultra-potent transmission-blocking antibody responses

Immunity
2022-09 | Journal article
Part of ISSN: 1074-7613
Contributors: Brandon McLeod; Moustafa T. Mabrouk; Kazutoyo Miura; Rashmi Ravichandran; Sally Kephart; Sophia Hailemariam; Thao P. Pham; Anthony Semesi; Iga Kucharska; Prasun Kundu et al.
Source: Self-asserted source
Max Johnson

Distinct sensitivities to SARS-CoV-2 variants in vaccinated humans and mice.

Cell reports
2022-08-15 | Journal article
WOSUID:

MEDLINE:35988541

Part of ISSN: 2211-1247
Contributors: Walls, Alexandra C.; VanBlargan, Laura A.; Wu, Kai; Choi, Angela; Navarro, Mary Jane; Lee, Diana; Avena, Laura; Berrueta, Daniela Montes; Pham, Minh N.; Elbashir, Sayda et al.
Source: check_circle
Stanford University

Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice

Science Translational Medicine
2022-05-25 | Journal article | Author
Part of ISSN: 1946-6234
Part of ISSN: 1946-6242
Contributors: Andrew Hunt; James Brett Case; Young-Jun Park; Longxing Cao; Kejia Wu; Alexandra Walls; Zhuoming Liu; John Bowen; Hsien Wei Yeh; Shally Saini et al.
Source: Self-asserted source
Max Johnson

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines.

Cell
2021-09-15 | Journal article
WOSUID:

MEDLINE:34619077

Part of ISSN: 1097-4172
Part of ISSN: 0092-8674
Contributors: Walls, Alexandra C.; Miranda, Marcos C.; Schafer, Alexandra; Pham, Minh N.; Greaney, Allison; Arunachalam, Prabhu S.; Navarro, Mary-Jane; Tortorici, M. Alejandra; Rogers, Kenneth; O'Connor, Megan A. et al.
Source: check_circle
Stanford University

Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design.

Frontiers in immunology
2021-06-29 | Journal article
Source: Self-asserted source
Max Johnson

Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease.

Cell host & microbe
2021-06-24 | Journal article
Source: Self-asserted source
Max Johnson

Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

Source: Self-asserted source
Max Johnson
grade
Preferred source (of 2)‎